Treatment of dyslipidemia in patients with type 2 diabetes
2010

Managing Cholesterol in Type 2 Diabetes

Sample size: 498 publication 10 minutes Evidence: moderate

Author Information

Author(s): Vijayaraghavan Krishnaswami

Primary Institution: Cardiovascular Division, Scottsdale Healthcare Research Institute, Scottsdale, AZ, USA

Hypothesis

How can dyslipidemia in patients with type 2 diabetes be effectively managed to reduce cardiovascular risk?

Conclusion

Many patients with type 2 diabetes do not achieve optimal lipid levels despite aggressive treatment, highlighting the need for improved management strategies.

Supporting Evidence

  • Dyslipidemia affects almost 50% of patients with type 2 diabetes.
  • Optimal lipid levels are not achieved in many patients despite treatment.
  • LDL-C management is crucial for reducing cardiovascular risk in diabetes.

Takeaway

People with type 2 diabetes often have bad cholesterol levels, which can lead to heart problems, so doctors need to help them get better cholesterol numbers.

Methodology

This review discusses the characteristics and prevalence of dyslipidemia in patients with type 2 diabetes and strategies for reducing cardiovascular risk.

Potential Biases

Potential bias in reporting due to the reliance on self-reported data from surveys.

Limitations

The review does not provide new experimental data but summarizes existing studies and guidelines.

Participant Demographics

The study references data from various populations, including 498 adults with type 2 diabetes from the NHANES survey.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-511X-9-144

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication